- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: PD-1 Receptor
I alt 62446 resultater
-
Ruhr University of BochumUkendt
-
AnaptysBio, Inc.RekrutteringRheumatoid arthritisForenede Stater, Argentina, Estland, Georgien, Ungarn, Mexico, Moldova, Republikken, Peru, Polen, Slovakiet, Belgien, Canada, Tyskland, Italien, Spanien
-
Affiliated Cancer Hospital & Institute of Guangzhou...Ikke rekrutterer endnuIkke småcellet lungekræft | EndostatinKina
-
Chinese PLA General HospitalUkendt
-
Huazhong University of Science and TechnologyUkendt
-
Hoffmann-La RocheAfsluttetBlærekræftForenede Stater, Spanien, Det Forenede Kongerige, Canada, Frankrig, Tyskland, Italien, Holland
-
Sun Yat-sen UniversityRekrutteringKlassisk Hodgkin lymfom | Refraktær eller recidiverende klassisk Hodgkin-lymfomKina
-
Nanfang Hospital of Southern Medical UniversityRekruttering
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRekrutteringStereotaktisk kropsstrålingsterapi; PD-1 inhibitor; hypertermi; NSCLCKina
-
Peking Union Medical College HospitalRekrutteringAnlotinib | Anti-PD-1 antistof | Avanceret kræft i bugspytkirtlenKina
-
Symphogen A/SAktiv, ikke rekrutterendeSolid tumor | Metastatisk kræftForenede Stater, Canada
-
Henlix, IncUkendt
-
Peking University Third HospitalUkendtLivmoderhalskræftKina
-
University Medical Center GroningenAktiv, ikke rekrutterendeLokalt avancerede eller metastatiske solide tumorer uanset PD-L1-ekspressionHolland
-
National Cancer Institute (NCI)Rekruttering
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetAvancerede solide tumorerKina
-
Merck Sharp & Dohme LLCAfsluttetIkke-småcellet lungekræftForenede Stater, Canada, Ungarn, Israel, Spanien
-
Jason J. Luke, MDRekrutteringMelanom | Livmoderhalskræft | Hepatocellulært karcinom | Mavekræft | Kolorektal cancer | NSCLC | Avancerede solide tumorer | Cholangiocarcinom | Blærekræft | Nyrekræft | Anal kræft | Merkel cellekarcinom | HNSCCForenede Stater
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... og andre samarbejdspartnereRekrutteringOnkologi | NSCLC trin IV | NSCLC, trin IIINorge
-
Beijing Tongren HospitalIkke rekrutterer endnuEkstranodal NK/T-celle lymfom, nasal type
-
Guangxi Medical UniversityUkendtHepatocellulært karcinom
-
Merck Sharp & Dohme LLCAfsluttet
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumAfsluttetIkke-småcellet lungekræftForenede Stater
-
PfizerRekrutteringMelanom | Neoplasmer | Nyrecellekarcinom | Ikke-småcellet lungekræft | Planocellulært karcinom i hoved og hals | Urothelialt karcinom | Kolorektalt karcinom | OvariekarcinomForenede Stater, Japan, Puerto Rico
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.Afsluttet
-
Shanghai Ninth People's Hospital Affiliated to...Fudan University; First Affiliated Hospital of Fujian Medical University; Tianjin Medical University Cancer Institute and Hospital og andre samarbejdspartnereRekrutteringPlanocellulært karcinom i hoved og halsKina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekrutteringAvanceret hepatocellulært karcinomKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RekrutteringKarcinom | Neoplasmer i fordøjelsessystemet | Intrahepatisk cholangiocarcinom | Førstelinjes behandling | PD-1 inhibitorKina
-
Hangzhou Cancer HospitalAnhui Kedgene Biotechnology Co.,LtdAfsluttet
-
Sun Yat-sen UniversityRekrutteringNasopharyngealt karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Changhai HospitalNational Natural Science Foundation of ChinaAfsluttet
-
Peking UniversityUkendtPatients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Aktiv, ikke rekrutterendeBlærekræftUngarn, Forenede Stater, Kina, Argentina, Australien, Bulgarien, Canada, Colombia, Kroatien, Tjekkiet, Frankrig, Tyskland, Grækenland, Israel, Italien, Japan, Korea, Republikken, Malaysia, Filippinerne, Polen, Portugal, Rumænien, Den... og mere
-
Peking University First HospitalYiZhou International Cancer HospitalUkendtNeoplasma Metastase | Immunterapi | Protonterapi
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... og andre samarbejdspartnereRekrutteringEsophageale neoplasmerKina
-
AkesoIkke rekrutterer endnu
-
Xiangya Hospital of Central South UniversityRekrutteringColon neoplasmer | Kemoterapi effektKina
-
AkesoAfsluttet
-
Sun Yat-sen UniversityInnovent Biologics (Suzhou) Co. Ltd.RekrutteringPancreas Adenocarcinom MetastatiskKina
-
Sun Yat-sen UniversityRekrutteringKolorektal cancer stadium IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)Kina
-
BeiGeneRekrutteringMSI-H/dMMR solide tumorerKina
-
The Second Affiliated Hospital of Harbin Medical...UkendtContract Management PD
-
University of LeipzigRekrutteringHepatocellulært karcinomTyskland
-
Merck Sharp & Dohme LLCAfsluttetEsophageal carcinom | Esophagogastric Junction CarcinomKina
-
Merck Sharp & Dohme LLCAfsluttet
-
Novartis PharmaceuticalsAfsluttetMelanom | Tredobbelt negativ brystkræft | Anaplastisk kræft i skjoldbruskkirtlen | Andre faste tumorer | Ikke-små sælgende lungekræft (NSCLC)Forenede Stater, Italien, Spanien, Ungarn, Taiwan, Tyskland, Holland, Frankrig, Norge, Polen, Thailand, Libanon, Kalkun, Canada
-
Shanghai Zhongshan HospitalRekruttering